Canadian Thoracic Society (CTS): Pharmacotherapy in Patients with COPD - 2019 Update of Evidence
This accredited e-CME provides updated evidence-based recommendations from the CTS 2019 Guideline on Pharmacotherapy in patients with COPD.
This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Thoracic Society. You may claim a maximum of 1 hour (credits are automatically calculated).
Mohit Bhutani (Chair), MD, FRCPC
Jean Bourbeau, MD, FRCPC
Paul Hernandez, MDCM, FRCPC
Darcy Marciniuk, MD, FRCPC
At the end of this presentation, participants will be able to:
- Summarize the recent updates in the new CTS Clinical Practice Guideline on Pharmacotherapy in patients with COPD – 2019 Update of Evidence;
- Integrate recommendations for maintenance pharmacotherapy to improve symptoms, quality of life and reduce the risk of acute exacerbations of COPD (AECOPD); and
- Demonstrate a practical [Canadian] approach and pharmacotherapy recommendations for optimizing management and outcomes for COPD patients.